Literature DB >> 12828961

Effect of alcohol on iron storage diseases of the liver.

Linda M Fletcher1, Kim R Bridle, Darrell H G Crawford.   

Abstract

The consumption of excess alcohol in patients with liver iron storage diseases, in particular the iron-overload disease hereditary haemochromatosis (HH), has important clinical consequences. HH, a common genetic disorder amongst people of European descent, results in a slow, progressive accumulation of excess hepatic iron. If left untreated, the condition may lead to fibrosis, cirrhosis and primary hepatocellular carcinoma. The consumption of excess alcohol remains an important cause of hepatic cirrhosis and alcohol consumption itself may lead to altered iron homeostasis. Both alcohol and iron independently have been shown to result in increased oxidative stress causing lipid peroxidation and tissue damage. Therefore, the added effects of both toxins may exacerbate the pathogenesis of disease and impose an increased risk of cirrhosis. This review discusses the concomitant effects of alcohol and iron on the pathogenesis of liver disease. We also discuss the implications of co-existent alcohol and iron in end-stage liver disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12828961     DOI: 10.1016/s1521-6918(03)00020-9

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  3 in total

1.  The relationship between serum ferritin levels and electrocardiogram characteristics in acutely ill patients.

Authors:  Krzysztof Laudanski; Huma Ali; Andrew Himmel; Kasia Godula; Mary Stettmeier; Lisa Calvocoressi
Journal:  Exp Clin Cardiol       Date:  2009

2.  Noninvasive liver-iron measurements with a room-temperature susceptometer.

Authors:  William F Avrin; Sankaran Kumar
Journal:  Physiol Meas       Date:  2007-03-07       Impact factor: 2.833

Review 3.  Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

Authors:  Quentin M Anstee; Robert D Goldin
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.